Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Margarida De Magalhaes-Silverman"'
Publikováno v:
Clinical Hematology International
Clinical Hematology International, Vol 2, Iss 2 (2020)
Clinical Hematology International, Vol 2, Iss 2 (2020)
Graft versus host disease (GVHD) of the gut is associated with significant morbidity and mortality after allogeneic hematopoietic cell transplant (allo-HCT). No guidelines exist regarding repeat endoscopy after failure of first-line treatment with st
Publikováno v:
American Journal of Therapeutics. 25:e701-e704
Autor:
David A. Jacobsohn, William T. Tse, Katharine E. Duckworth, Marcie L. Riches, Ruthee-Lu Bayer, Andrew S. Artz, J. Douglas Rizzo, Edward D. Ball, Indira Sahdev, Deidre M. Kiefer, Daniel J. Weisdorf, John P. Miller, Paolo Anderlini, Christopher C. Dvorak, Carolyn Bigelow, Shalini Shenoy, Michael L. Linenberger, Michael A. Pulsipher, Pintip Chitphakdithai, Brian J. Bolwell, Rebecca J. Drexler, David C. Delgado, Aly Abdel-Mageed, Jane L. Liesveld, Edmund K. Waller, E. Randolph Broun, Hillard M. Lazarus, Ann A. Jakubowski, O'Susan F Leitman, Margarida De Magalhaes-Silverman, Luke P. Akard, Willis H. Navarro, Gregory A. Yanik, Parameswaran Hari, Paul J. Shaughnessy, Galen E. Switzer, Shahram Mori, Witold B. Rybka, Vinod K. Prasad, Vinod Parameswaran, Joseph P. Uberti, Theresa Hahn, Ibrahim Ahmed, George B. Selby, Kimberly A. Kasow, Scott D. Rowley, Ann E. Haight, Brent R. Logan, Mark R. Litzow, Jeffrey Schriber, Dennis L. Confer, Thomas R. Spitzer, John M. McCarty, Hati Kobusingye, Madhuri Vusirikala, Bronwen E. Shaw, Brandon Hayes-Lattin, Walter L. Longo, Joseph P. McGuirk, RaeAnne M. Besser, Mary M. Horowitz
Publikováno v:
Haematologica
Haematologica, vol 104, iss 4
Haematologica, vol 104, iss 4
Unlike unrelated donor registries, transplant centers lack uniform approaches to related donor assessment and deferral. To test whether related donors are at increased risk for donation-related toxicities, we conducted a prospective observational tri
Autor:
Hati Kobusingye, David A. Jacobsohn, Matthew D. Seftel, Galen E. Switzer, Madhuri Vusirikala, Brent R. Logan, Michael A. Pulsipher, Margarida De Magalhaes-Silverman, Pintip Chitphakdithai, John P. Miller, Michael L. Linenberger, Bronwen E. Shaw, Mark R. Litzow, Andrew S. Artz, Ann E. Haight, Dennis L. Confer, Mary M. Horowitz, George B. Selby
Publikováno v:
Transplant Cell Ther
The incidence and risk factors for severe adverse events (SAEs) in related donors (RD) of hematopoietic cell transplants is unknown. The Related Donor Safe (RDSafe) study is a prospective observational cohort of 1680 RDs, and represents an opportunit
Autor:
Bronwen E. Shaw, Margarida De Magalhaes-Silverman, James W. Varni, Edward D. Ball, Indira Sahdev, Deidre M. Kiefer, William T. Tse, Michael L. Linenberger, Gregory A. Hale, Galen E. Switzer, Shahram Mori, Jeffrey Schriber, Nancy Bunin, Dennis L. Confer, Susan F. Leitman, Marcie L. Riches, Hati Kobusingye, Michael A. Pulsipher, Mary M. Horowitz, Ibrahim Ahmed, Alfred P. Gillio, Rebecca J. Drexler, Pintip Chitphakdithai, Aly Abdel-Mageed, Brian J. Bolwell, John P. Miller, Alexandra Cheerva, David C. Delgado, Willis H. Navarro, Brandon Hayes-Lattin, RaeAnne M. Besser, Kimberly A. Kasow, Brent R. Logan, Paolo Anderlini, Vinod K. Prasad, Theresa Hahn, Ann E. Haight, Christopher C. Dvorak, J. Douglas Rizzo, Shalini Shenoy, Troy C. Quigg, Gregory A. Yanik
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol 25, iss 5
Biol Blood Marrow Transplant
Biol Blood Marrow Transplant
Although donation of bone marrow (BM) or peripheral blood stem cells (PBSCs) from children to family members undergoing allogeneic transplantation are well-established procedures, studies detailing levels of pain, symptoms, and long-term recovery are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f073b9743e117b602578aa75af7fc05d
https://escholarship.org/uc/item/77k4j17w
https://escholarship.org/uc/item/77k4j17w
Autor:
Ann A. Jakubowski, Galen E. Switzer, Joseph P. Uberti, Hillard M. Lazarus, James W. Varni, Rebecca J. Drexler, Scott D. Rowley, Jane L. Liesveld, Michael A. Pulsipher, Joseph P. McGuirk, Pintip Chitphakdithai, Witold B. Rybka, Gregory A. Yanik, Nancy Bunin, Walter L. Longo, Parameswaran Hari, Shahram Mori, Hati Kobusingye, John M. McCarty, Madhuri Vusirikala, Brian J. Bolwell, E. Randolph Broun, Paul J. Shaughnessy, Paolo Anderlini, David C. Delgado, R.L. Bayer, David A. Jacobsohn, Ibrahim Ahmed, Christopher C. Dvorak, Susan F. Leitman, Dennis L. Confer, Thomas R. Spitzer, George B. Selby, Daniel J. Weisdorf, Bronwen E. Shaw, Margarida De Magalhaes-Silverman, Andrew S. Artz, J. Douglas Rizzo, Shalini Shenoy, Vinod K. Prasad, Theresa Hahn, Brandon Hayes-Lattin, Ann E. Haight, Edward D. Ball, Indira Sahdev, Deidre M. Kiefer, Jeffrey Schriber, Michael L. Linenberger, Mark R. Litzow, Aly Abdel-Mageed, Rae Anne M. Besser, Luke P. Akard, Willis H. Navarro, William T. Tse, Carolyn Bigelow, Marcie L. Riches, John P. Miller, Edmund K. Waller, Mary M. Horowitz, Katharine E. Duckworth, Kimberly A. Kasow, Brent R. Logan
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol 25, iss 4
The development of reduced-intensity approaches for allogeneic hematopoietic cell transplantation has resulted in growing numbers of older related donors (RDs) of peripheral blood stem cells (PBSCs). The effects of age on donation efficacy, toxicity,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b986c96f62ebd7f5f48dcb6d591c27e1
https://escholarship.org/uc/item/0n79d4dx
https://escholarship.org/uc/item/0n79d4dx
Autor:
Katharine E. Duckworth, Dennis L. Confer, Jeffrey Schriber, Thomas R. Spitzer, Brian J. Bolwell, Mary M. Horowitz, Mark R. Litzow, Ibrahim A. Ahmed, Edmund K. Waller, Aly Abdel-Mageed, Edward D. Ball, Ruthee-Lu Bayer, Andrew S. Artz, Kimberly A. Kasow, David C. Delgado, Hillard M. Lazarus, Parameswaran Hari, Indira Sahdev, Witold B. Rybka, Brent R. Logan, Deidre M. Kiefer, Shahram Mori, Carolyn Bigelow, Bronwen E. Shaw, Scott D. Rowley, Galen E. Switzer, Willis H. Navarro, Michael L. Linenberger, Michael A. Pulsipher, Luke P. Akard, John M. McCarty, Pintip Chitphakdithai, E. Randolph Broun, Daniel J. Weisdorf, Jane L. Liesveld, Rebecca J. Drexler, David A. Jacobsohn, Nancy Bunin, Walter L. Longo, Margarida De Magalhaes-Silverman, Paul J. Shaughnessy, Gregory A. Yanik, Susan F. Leitman, Hati Kobusingye, Brandon Hayes-Lattin, RaeAnne M. Besser, Paolo Anderlini, Madhuri Vusirikala, Marcie L. Riches, John P. Miller, William T. Tse, James W. Varni, George B. Selby, Vinod K. Prasad, Vinod Parameswaran, Theresa Hahn, Ann E. Haight, Christopher C. Dvorak, Ann A. Jakubowski, J. Douglas Rizzo, Joseph P. Uberti, Shalini Shenoy, Joseph P. McGuirk
Publikováno v:
SSRN Electronic Journal.
Background: The development of reduced intensity approaches for allogeneic hematopoietic cell transplantation has resulted in growing numbers of older related donors (RD) of PBSC. The effects of age on donation efficacy, toxicity, and long-term recov
Publikováno v:
Case Reports in Infectious Diseases, Vol 2018 (2018)
Case Reports in Infectious Diseases
Case Reports in Infectious Diseases
Infection withToxoplasma gondiiis a rare but often fatal complication in hematopoietic stem cell transplantation (HSCT) recipients. Most cases have been reported in allogeneic (allo-) HSCT recipients, with only narrative reports following autologous
Autor:
Priscille M. Bourquelot, Margarida De Magalhaes-Silverman, Bourras Rezki Bengoudifa, Rafat Abonour, Kenneth C. Anderson, Katharine Hazell, Hartmut Goldschmidt, Jeffrey Matous, Jeffrey L. Wolf, Ravi Vij, David S. Siegel, Sagar Lonial
Publikováno v:
Leukemia & Lymphoma. 53:1820-1823
Novel therapies such as bortezomib and immunomodulatory agents (IMiDs®) have significantly improved the survival of patients with multiple myeloma (MM) [1]. However, the prognosis remains poor for ...
Autor:
Carlos E. Vigil, Margarida De Magalhaes-Silverman, Jennifer Weis, Thomas H. Carter, K D Heckman, Oana Paun, Nusrat Jahan
Publikováno v:
Journal of Clinical Oncology. 35:e18515-e18515
e18515 Background: The outcome of genetically high risk acute myeloid leukemia (AML) patients (pts) remains poor, with a median overall survival (OS) of a few months after the failure of regimens. Long-term survival requires complete remission follow